Cerebral Palsy Treatment in Hyderabad: The Brain Injury Is Static — But What Happens to the Body Is Not. Early, Structured Management Changes the Outcome.

Birth asphyxia is one important cause of Cerebral Palsy among several — prenatal factors such as brain malformations, prenatal stroke, intrauterine infection and genetic causes account for a large share, and in many children no single cause is identified. A NICU stay for hypoxic-ischaemic encephalopathy (HIE) does identify your child as at risk. Not all children with birth asphyxia develop CP — the outcome depends on the severity and duration of the oxygen deprivation and the degree of brain injury. The way to know: structured developmental follow-up. At KIMS, we recommend that any child with a history of birth asphyxia requiring NICU care should be enrolled in a developmental monitoring programme from discharge. Key milestones to watch: head control by 4 months, sitting by 9 months, and walking by 18 months. Signs that should prompt urgent assessment: persistent fisting of hands after 3 months, leg stiffness, early hand preference before 12 months, or toe-walking when standing begins. Please call 040-44885000 to arrange an early developmental assessment at KIMS.

Toe-walking in spastic diplegic CP is caused by spasticity (over-activity) of the calf muscles, specifically the gastrocnemius and soleus, pulling the ankle into the equinus (plantar-flexed, toe-down) position. At this age, the management sequence at KIMS typically includes: (1) Botulinum toxin injection into the gastrocnemius and soleus muscles — reducing the muscle overactivity for 3–4 months, during which intensive physiotherapy and sometimes serial casting work to stretch the muscles and train heel-toe gait; (2) Ankle-foot orthoses (AFOs) worn during waking hours to hold the foot in a more functional position and prevent contracture progression; (3) Gait physiotherapy — training heel-strike, single-leg balance, and stair-climbing; (4) If the toe-walking is caused by fixed tendon shortening rather than dynamic spasticity, Achilles tendon lengthening surgery is planned, typically not before age 5–6 to allow maximal non-surgical management. Please call 040-44885000 to arrange a KIMS spasticity assessment.

For a child with severe generalised spasticity who cannot sit independently (this sounds like GMFCS IV–V), the management at KIMS focuses on two parallel goals: reducing the spasticity enough to make positioning, seating, and care easier for the family and child; and preventing the secondary complications of severe spasticity (hip dislocation, scoliosis, painful contractures). Oral baclofen is typically tried first and provides meaningful benefit in many children — it can be started at KIMS and the dose titrated over weeks based on response and sedation. If oral baclofen is inadequate or produces unacceptable sedation at effective doses, an intrathecal baclofen pump — a small device implanted under the skin delivering baclofen directly into the spinal fluid — provides better spasticity reduction with less sedation. Botulinum toxin to the most problematic individual muscle groups is used in parallel for focal problem areas (hip adductors for scissoring, hamstrings for positioning difficulty). Call 040-44885000.

Yes — and the timing matters. The affected arm in hemiplegic CP typically has the same potential for improvement as the leg, but the child naturally prefers the unaffected arm and the affected arm receives less motor practice, reducing its development. The most evidence-based intervention for this is Constraint-Induced Movement Therapy (CIMT): the unaffected arm is placed in a cast or a padded mitt for a period (typically 2–6 weeks) while the child undergoes intensive therapy forcing use of the affected arm for daily tasks. This works best in children aged 2–8 years when neuroplasticity is greatest. Botulinum toxin to the wrist and finger flexors is used when spasticity in those muscles limits hand opening and grip. The KIMS therapy team will assess your daughter's upper limb function using the MACS classification and design a targeted hand therapy programme. Call 040-44885000.

Dyskinetic (choreoathetoid) CP from kernicterus presents a specific management challenge: spasticity-reducing treatments that work well in spastic CP (botulinum toxin, baclofen, SDR) are much less effective in dyskinetic CP, because the abnormal movements arise from basal ganglia dysfunction rather than spasticity. However, there are specific options at KIMS. Deep Brain Stimulation (DBS) — the same technique used for Parkinson's disease at KIMS — has been used in selected patients with dyskinetic CP to reduce the severity of involuntary movements. The evidence base is growing, patient selection is highly specific, and results are variable but can be meaningful in carefully chosen cases. For speech, AAC (augmentative and alternative communication) devices — including eye-gaze technology for children with severe motor impairment — enable communication despite the inability to produce intelligible speech. Please call 040-44885000 for a KIMS assessment of your son's specific situation.

Drug-resistant epilepsy — seizures not controlled by two adequate trials of appropriate anti-seizure medications — occurs in a significant proportion of CP children with epilepsy and requires specialist reassessment at KIMS. The steps at KIMS for a CP child with drug-resistant epilepsy are: (1) Review whether the current medications are the right ones for the specific seizure type — selecting the wrong anti-seizure medication for the seizure type is a common reason for apparent drug resistance; (2) Arrange a video-EEG to precisely characterise the seizure type and electrographic pattern; (3) MRI brain review — specifically to determine whether there is a focal cortical lesion that could potentially be surgically removed; (4) If the CP has an underlying structural lesion (focal cortical dysplasia, porencephaly, hemimegalencephaly), epilepsy surgery evaluation at KIMS may be appropriate and can be curative; (5) Dietary therapy (modified Atkins or ketogenic diet) is an option for children where surgery is not possible. Please call 040-44885000.

Hip problems in CP — progressive subluxation and dislocation — are common in non-ambulant children (GMFCS III–V) and occur because the spastic hip adductor and iliopsoas muscles pull the femoral head out of the acetabulum (hip socket) as the child grows. This is a well-recognised and predictable complication, which is why KIMS conducts hip surveillance X-rays in all non-ambulant CP children. Surgery is recommended when the femoral head has migrated sufficiently to be at risk of dislocation or when dislocation has already occurred — because a dislocated hip in CP causes severe, often untreatable pain. The surgical procedures (femoral osteotomy, acetabular reconstruction) are well-established at KIMS and safe under appropriate anaesthetic management. The anaesthetic team is briefed on the specific considerations in CP (swallowing difficulty, secretion management, temperature regulation). The outcome of hip surgery in CP is generally good for pain relief and positioning, though walking ability does not typically improve. Please call 040-44885000 to arrange a pre-surgical assessment.